SCHEMBL8167369

SCHEMBL8167369

Cn1cc(C2=C(c3cccc(Cl)c3)C(=O)NC2=O)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.74
PRKCA P17252 4/20 0.74
GSK3A P49840 2/20 0.72
CDK4 P11802 2/20 0.72
CCND1 P24385 2/20 0.72
CDK2 P24941 2/20 0.72
MEN1 O00255 1/20 0.72
RGS12 O14924 1/20 0.72
GMNN O75496 1/20 0.72
USP2 O75604 1/20 0.72
CCNB2 O95067 1/20 0.72
LMNA P02545 1/20 0.72
TP53 P04637 1/20 0.72
CYP1A2 P05177 1/20 0.72
CDK1 P06493 1/20 0.72
POLB P06746 1/20 0.72
CYP3A4 P08684 1/20 0.72
CYP2D6 P10635 1/20 0.72
MAPT P10636 1/20 0.72
CYP2C9 P11712 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8161928 0.90 CDK4 (0.74) GSK3BPRKCAGSK3ACDK4CCND1
SCHEMBL8154180 0.86 GSK3B (0.76) GSK3BPRKCACDK4CCND1CDK2
SCHEMBL8163218 0.86 GSK3B (0.81) GSK3BPRKCAGSK3ACDK4CCND1
SCHEMBL8153807 0.86 GSK3B (0.81) GSK3BPRKCAGSK3ACDK4CCND1
SCHEMBL8154922 0.86 GSK3B (0.81) GSK3BPRKCAGSK3ACDK4CCND1
SCHEMBL6950992 0.86 GSK3B (0.94) GSK3BPRKCACDK4CCND1CDK2
SCHEMBL8161270 0.85 GSK3B (0.74) GSK3BPRKCACDK4CCND1CDK2
SCHEMBL4427029 0.85 GSK3B (1.00) GSK3BPRKCACDK4CCND1CDK2
SCHEMBL29396453 0.85 GSK3B (1.00) GSK3BPRKCACDK4CCND1CDK2
SCHEMBL29359337 0.85 GSK3B (1.00) GSK3BPRKCACDK4CCND1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36736-E Substituted pyrroles HOFFMAN-LA ROCHE INC. (US) 2000-06-13 US disclosed
EP-0328026-B1 SUBSTITUTED PYRROLES F. HOFFMANN-LA ROCHE AG (CH) 1993-04-28 EP disclosed
US-5057614-A Antiinflammatory, immunology, bronchodilator agents, cardiovascular disorders HOFFMANN-LA ROCHE INC. (US) 1991-10-15 US disclosed
EP-0328026-A1 Substituted pyrroles F. HOFFMANN-LA ROCHE AG (CH) 1989-08-16 EP disclosed